Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding ...

Companies aren't slowing down to ask if AI is ready for mental health; they're racing to build it in. Encoding the same ...

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same ...

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and ...

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed ...

Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease ...

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical ...

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near ...

For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ...

Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics.